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BACKGROUND: Umbilical Cord Blood (UCB) has been widely use as regenerative medicine due to the content of undifferentiated cell which have 
capability to do self-renewal and differentiation into various 
type of cell called stem cells. Recent studies show that UCB 
contains not only hematopoietic stem cell (HSC) but also 
others stem cell and progenitor cell such as endothelial 
progenitor cell (EPC) and very small embryonic-like stem 
cell (VSEL). It is beliefs that HSC and EPC shared the 
same progenitor. In this study, correlation between the cell 
number of HSC, EPC and VSEL is analyzed in umbilical 
cord blood as the source of stem cell for clinical application. 
METHODS: The cell number of HSC, EPC and VSEL 
is counted from cryopreserved UCB collected from 22 
women delivered via cesarean section which already stored 
for more than 2 years in this study. Sample were incubated 
with antibodies such as cluster of differentiation (CD)34-
phycoerythrin (PE)/CD45-fluorescein isothiocyanate 
(FITC), CD133/1 (anti-CD (AC)133)-antigen-presenting 
cell (APC) and, CD184 (C-X-C chemokine receptor 
(CXCR)4)-PE.Vio770 to detect the present of HSC, EPC and 
VSEL in UCB. Sample were analyze using flowcytometer 
BD FACS Canto II.
RESULTS: The cell population of HSC and late-EPC 
is 0.009% and 0.01% of total cell in UCB. VSEL only 
represented 0.001% from total cell in UCB, showing 
the lowest  number  of  cell  population  in  UCB.  The 
correlation between the cell number of HSC and EPC 
is r=0,483*, p=0.023) and between HSC and VSEL is 
r=0.510*, p=0.015. 
CONCLUSION: In this study, both EPC and VSEL have a 
significant positive correlation with HSC. 
KEywORDS: stem cell, umbilical cord blood, endothelial 
progenitor, flowcytometry
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Abstract
Introduction
Vascular  repair  and  endothelial  restoration  in 
atherosclerotic disease affected with endothelial progenitor 
cells (EPC). However, isolating EPC from pheripheral 
bloods remain difficult as they are a very rare population 
of cells.(1) The alternative source of EPC are bone marrow 
and  umbilical  cord  blood.  Umbilical  Cord  Blood  (UCB) 
has been  widely  use  as  regenerative  medicine  due  to 
the content of hematopoietic stem cell (HSC).(2) Moreover, 
UCB also served as the source of undifferentiated cell which 
have  capability  to  do  self-renewal  and  differentiation 
into various type of cell called stem cells.(3) Stem cells are 
defined  as  cell  that  have  the  ability  to  self-renew  and 
to differentiate into specialized cell.(4) Stem cell population 
in UCB have multipotent characteristic, which are able to 
differentiate  into  various  type  of  cell.(5)  Every type 
of stem  cell  has  a  different  function  in  regenerative 
medicine  therapy.(6)  Recent  studies  show  that  UCB 
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contains not only  HSC  but also  others  stem  cell  and 
progenitor  cell.  Cell  such  as  endothelial  progenitor  cell 
(EPC)  and  very small embryonic-like stem cell (VSEL) are 
found in UCB.(7) 
 Hematopoeitic and vascular endothelial progenitor 
cell share the same antigens expression on cell surface 
marker.(8) The function of the both cell were differentiate 
such as HSC is to form blood cells and EPC is to form 
blood vessels.(9) Human endothelial progenitor cells 
firstly  found as  circulationg  cell  that  is  use  to  promote 
the vasculogenesis in repairing the blood vessel.(8,10) 
Neovascularization is an important process for tissue repair 
and regeneration.(9) In the process of neovascularization, 
EPC will differentiate into endothelial cells to repair the 
injured tissue. EPC will also secrets growth factors to induce 
the activation of endogenous stem cell in human body.(11)
 Others stem cell found in UCB is VSEL, a pluripotent 
cell which have potency to differentiate and plays role 
in tissue regeneration and repair.(12) VSEL expressed 
CXCR4+ antigen cell surface marker and significantly 
smaller than HSC.(13) According to Guerin, et al., VSEL 
show the capability to differentiate into endothelial cell 
when  mobilized  into  critcal  limb  ischemic  patient.
(14) Such abilities to differentiate into many types of cell 
is decribed by Ratajczak, et al., show that VSEL have 
pluripotency capacity which is important in cell regenrative 
and therapy.(15)
 When transplanted due to injury, UCB-derived cells 
shown to contribute in the tissue regeneration of skeletal 
muscle, neural, and myocardial.(16) Thus makes stem cell 
as a promising treatment to cure the incurable diseases.
(17,18) Those function makes UCB as an important source 
of stem cell. In this study, correlation of the cell number 
between HSC, EPC and VSEL was analyzed in umbilical 
cord blood as the source of stem cell for clinical application, 
especially for cardiac and neurologiacal disorder.   
Methods
This study is conducted in Prodia Stem Cell Laboratory after 
received ethical clearence No. 1001/UN6/C10/PN/2017 
from Health Research Ethic Committee Medical Faculty 
Padjajaran University. 
Cell Staining and Flowcytometry Detection
Cryopreserved UCB which already stored for more than 
2 years were thawed in 37°C. Antibodies such as cluster 
of differentiation (CD)34-phycoerythrin (PE)/CD45-
fluorescein isothiocyanate (FITC) (BD Bioscience, San 
Jose, CA, USA), CD133/1 (anti-CD (AC)133)-antigen-
presenting cell (APC) (Miltenyi Biotec GmbH, Bergish, 
Germany), CD184 (C-X-C chemokine receptor (CXCR)4)-
PE.Vio770 (Miltenyi Biotec GmbH) were add to each 
samples in a BD Trucount tube (BD Bioscience). Sample 
were incubated for 30 minutes in dark. BD FACS Lysing 
Solution 1x (BD Bioscience) were added to each sample 
tube and incubated for 10 minutes. All sample were run in 
BD FACS Canto II.
Cell Number Count
Cell number were counted as decribed in manul instruction 
for BD Trucount tube to get cell number/mL. 
Results
Sample Profile
UCB were collected from from 22 women delivered via 
cesarean section. Gestation age is over 36 weeks.
HSC, EPC, and VSEL number in UCB
Calculated cell number is conducted from event counted 
in flowcytometry with gating strategy for HSC, EPC, and 
VSEL (Figure 1). HSC represented antibody marker CD34+ 
and CD45dim. Population of EPC showed by antibody 
marker CD45-, CD34+ and CD133+. VSEL is detected using 
antibody marker CD45- and CD184(CXCR4)+. 
 Cell number counted in UCB show that late-EPC 
have the highest concentration compare to HSC dan VSEL 
(Tabel 1). The proportion of HSC and late-EPC is 0.009% 
and 0.01% of the total population of cell in UCB. VSEL 
only represented 0.001% from total cell in UCB, showing 
the lowest number of cell population in UCB. 
Table 1. Cell Number in UCB.
HSC (103 cell/mL) 35.62 34.903 0.01%
Late- EPC (103 cell/mL) 54.38 70.402 0.01%
VSEL (103 cell /mL) 5.04 5.775 0.00%
SD Proportion (%)
Mean
(n=22)
Correlation between HSC and EPC and VSEL in UCB
Correlation test using Spearman Correlation test show 
that in Tabel 2. EPC and VSEL have significant positive 
correlation with HSC.
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Figure 1. Gating strategies for HSC, late-EPC and VSEL. A: HSC using CD45-FITC and CD34-PE; B: Late-EPC using CD45-FITC, 
CD34-PE and CD133-APC; C: VSEL using CD45-FITC and CXCR4-PE.Vio770.
Discussion
Cell Number of HSC, EPC and VSEL in UCB
Umbilical cord blood already known as source of HSC. 
It was reported in previous study that HSC under the 
expression of CD34+ found in UCB is 0.02-1.43% of the 
total cell population.(19) In this study, the number of HSC 
under the expresion of CD34+ and CD45- is 0.009%, slightly 
lower than the reference number. 
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 Late-EPC detected in this study show the highest 
number of cell population in UCB. This might due to the 
differentiation of the early-EPC into late-EPC. Regulation 
of angiogenesis is depending on the biological properties of 
EPC. The finding of higher late-EPC number in UCB show 
that UCB have more potency to be used as regenerative 
medicine for cascular repair and endothelial restoration. 
Late-EPC show to have more proliferation and angiogenesis 
genes which is used for the neovascularization compare to 
early-EPC.(20)  Very small embryonic-like stem cell show 
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EPC VSEL
r=0.483* r=0.510*
p =0.023 p =0.015
HSC
Table 2. Correlation between HSC and other cell in UCB. 
(n=22)
Note: *significant p<0.005, r: coeficient correlation
to have the lowest number compare to the others cell in 
UCB. VSEL are a small cell which are smaller than HSC 
(21) that express CXCR4, CD34, and CD133 surface 
marker.(13) Isolation of VSEL from UCB by Hasala, et al., 
show that the population of VSEL is less than 0.2%.(22)
Correlation between Hematopoietic Stem Cell and Late-
Endothelial Progenitor Cell 
Positive correlation (r=0.483*, p=0.023) show between the 
cell number of HSC and EPC. Hemangioblast, a common 
mesodermal  precursor  is  believed  as  the  cellular origin of 
HSC and EPC.(23,24) Hemagioblast is a bi-potent progenitor 
that could give rise to angioblast and hematopoiesis.(25) 
This idea came from the evidence of blood islands structure 
which are a layer of endothelial cell which surrounded the 
first blood cell.(26) 
 There is a theory that believe that the HSC will 
differentiate into hematopoietic progenitor cell and will 
produce EPC. EPC then differentiated into endothelial 
cells which will built the new blood formation called 
vasculogenesis or form a new capillaries from pre-exiting 
vessel called angiogenesis.(1,27). Both of the process 
need EPC which directly form new and provide growth 
factor needed for the process.(27) EPC have function to do 
vascular repairment and repairing endothel dysfunction by 
replacing the damage cell.(24) 
Correlation between Hematopoietic Stem Cell and Very 
Small Embryonic-like Stem Cell
VSEL is believe as an envision from the germ lineage of 
epiblast derived cell that deposited in early gastrulation 
or embryogenesis. This origin causes the VSEL to 
express several pluripotent markers characteristic.(12,21) 
Hematopoietic stem cell shows to have positive correlation 
with VSEL (r=0.510*, p=0.015). This correlation might 
because the ability of VSEL to give rise into long term HSC 
(LT-HSC), which has the capability to repopulation itself. 
Naturally, VSEL didn’t express CD45 surface marker but 
when needed VSEL could differentiate into tissue commited 
stem cell if needed. CD45- VSEL might differentiate into 
Conclusion
Hematopoietic stem cell, endothelial progenitor cell, and 
very small embryonic stem cell number found in umbilical 
cord blood show positive correlation between HSC and 
EPC also between HSC and VSEL.
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